The elderberry portfolio includes extracts standardized to 6% and 10% anthocyanins in both standard and organic grades.
Photo © stock.adobe.com/romankrykh
PLT Health Solutions (Morristown, NJ) announced that it will be offering new elderberry extracts to the North American market. The elderberry portfolio includes extracts standardized to 6% and 10% anthocyanins in both standard and organic grades. Nektium Pharma (Las Palmas, Spain), PLT’s innovation partner, has secured long-term supply agreements with black elderberry growers in Central Europe, and will extract finished products at its facilities in the Canary Islands. The ingredients go through a per-batch testing program to ensure quality. These tests include fingerprint analysis for identification and quantification of anthocyanins, DNA sequential barcoding for authenticity, analysis for adulteration using the MALDI TOF technique, and standardization of biomarkers.
"As often happens with plant-based materials when demand spikes rapidly, there was a shortage of elderberry materials and a proliferation of sub-standard and adulterated products entering the market. All of us have read headlines of inferior elderberry offerings in the media," said Steve Fink, vice president of marketing for PLT Health Solutions, in a press release. "It has long been the mission of PLT Health Solutions to address industry pain points and to solve problems. With this line of traceable, standardized and lab-tested elderberry extracts, we believe PLT and Nektium have done that. Our organic offering adds additional value and can help our customers differentiate their products in the marketplace.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.